P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
AGEN | N/A | N/A | N/A | +89.96% |
AGEN Peer | 3.6 | 7.5 | N/A | N/A |
Biotechnology Industry | 16.2 | 21.3 | 0.3 | +695.82% |
Health Technology Sector | 39.2 | 29.4 | 0.5 | +76.25% |
S&P 500 Market | 30.1 | 22.4 | 2.1 | +73.70% |
Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.21 | -$0.20 | -$0.19 | -$0.19 |
Previous Mean | -$0.15 | N/A | -$0.19 | -$0.19 |
Standard Deviation | 0.02 | 0.00 | 0.00 | 0.01 |
Low Estimate | -$0.23 | -$0.20 | -$0.19 | -$0.19 |
High Estimate | -$0.19 | -$0.20 | -$0.19 | -$0.18 |